FDA Approves Qsymia for Chronic Weight Management in Certain Pediatric Patients Aged 12 years and Older
June 27, 2022 -- The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in pediatric patients aged 12 years and older who are...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: Adipex | Drugs & Pharmacology | Food and Drug Administration (FDA) | Pediatrics | Phentermine | Topamax